​

CDT Equity Stock (NASDAQ:CDT)

RevenueOwnershipFinancialsChart
CDT Equity by TradingView

Previous Close

$2.96

52W Range

$2.60 - $1.75K

50D Avg

$11.77

200D Avg

$114.43

Market Cap

$486.31K

Avg Vol (3M)

$86.56K

Beta

2.08

Div Yield

-

CDT Company Profile

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

6

IPO Date

Mar 28, 2022

Website

CDT Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 24
Automation Solutions$1.32B

Fiscal year ends in Dec 25 | Currency in USD

CDT Financial Summary

Dec 25Dec 24Dec 23
Revenue$2.72B--
Operating Income$315.69M$-15.42M$-5.26M
Net Income$237.52M$-17.80M$-535.00K
EBITDA$315.69M$-15.84M$3.05M
Basic EPS$6.00$-20.53$-3.60
Diluted EPS$5.91$-20.53$-3.60

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
XAGELongevity Health Holdings Inc.
COCHEnvoy Medical, Inc.
ZVSAZyVersa Therapeutics, Inc.
WORXSCWorx Corp.
LIXTLixte Biotechnology Holdings, Inc.
PTPIPetros Pharmaceuticals, Inc.
CCMConcord Medical Services Holdings Limited
NIVFNewGenIvf Group Limited
ENVBEnveric Biosciences, Inc.